Vive Crop Protection has secured Canadian registration for its newest fungicide, Phobos FC360, a next-generation foliar treatment designed to deliver stronger disease control and better performance on crop leaves.
The product is powered by the company’s Allosperse Delivery Technology and contains the active ingredient prothioconazole, a Group 3 fungicide widely used to combat major crop diseases. Phobos FC360 is approved for use on several key Canadian crops, including canola, spring and winter wheat, barley, chickpeas, pulses and specialty crops.
Canadian farmers often contend with unpredictable weather and heavy disease pressure across diverse growing regions. According to Vive Crop Protection, Phobos™ FC360 was developed specifically to perform in those challenging conditions.
The foliar fungicide can be easily mixed with liquid fertilizers, micronutrients and other crop inputs, simplifying tank mixes during spraying. Unlike some competing products that can ridge or clump on leaf surfaces, the company says the formulation spreads evenly across leaves and resists being washed away by rain.
That improved retention means the product stays where it is sprayed, helping farmers protect crops more effectively and avoid losing fungicide to runoff.
“Canadian growers are looking for solutions that deliver consistent disease control without adding complexity to their spray programs,” said Wade Clarke, National Business Development Manager, Canada, Vive Crop Protection.
“Phobos FC360 brings a clear application advantage, stronger on-leaf retention, even coverage, and proven performance across Canada. We’re excited to provide growers with another tool that helps protect yield potential and maximize the value of every acre.”
Field trials conducted across Canada in 2025 showed Phobos FC360 delivered reliable disease control and competitive — and in some cases higher — yields compared with leading industry standards.
In canola trials in Manitoba and North Dakota, the fungicide consistently controlled sclerotinia stem rot, matching or outperforming other prothioconazole products in both disease suppression and yield. Winter wheat tests in Ontario found the product performed comparably to competing standards under heavy fusarium head blight pressure while maintaining strong DON suppression.
Spring wheat trials in Manitoba produced top yields and low DON levels, along with strong suppression of foliar diseases such as Septoria, tan spot and leaf rust. In barley, the fungicide reduced the incidence and severity of fusarium head blight and produced yields comparable to competing treatments.
Trials in Nova Scotia’s low-bush blueberry fields also showed improved control of monilinia blight and rust, alongside higher yields compared with competing products.
According to Vive Crop Protection, the results highlight the advantage of improved deposition and retention on leaf surfaces — especially in regions prone to rain and high humidity.
_195_291.jpg)
